On Thursday, the FDA’s Center for Veterinary Medicine announced final Guidance for Industry #61, entitled “Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species,” in order to better facilitate the availability of safe and effective new animal drugs for minor uses and minor species.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, December 22, 2023
Wednesday, December 20, 2023
Olympus Recalls Bronchofiberscopes and Bronchovideoscopes
CVM is sharing this announcement because these devices may be used in veterinary settings.
Olympus Corporation of the Americas is recalling bronchofiberscopes and bronchovideoscopes because they can lead to burns and fire.
Using the bronchoscopes may cause serious adverse health consequences including critical burns in a person’s airways or lungs, airway bleeding, trouble breathing, apnea, loss of consciousness, or death.
Please be aware, this recall is a correction, not a product removal.
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
Questions?
If you have questions about this recall, contact Olympus at 1-800-848-9024 (option 1)
Midland Vet Services | ||
|